Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

In vitro performance of combinations of anti-siphon devices with differential pressure valves in relation to the spatial position.

Fiss I, Vanderheyden M, von der Brelie C, Bettag C, Hore N, Freimann F, Thomale UW, Rohde V, Brandner S.

Acta Neurochir (Wien). 2020 Jan 30. doi: 10.1007/s00701-020-04228-6. [Epub ahead of print]

PMID:
31997071
2.

Impact of increased venous pressure on kidney function and mortality in cardiovascular patients with preserved ejection fraction.

Milkas A, Tsioufis K, Koliastasis L, Tsiamis E, Tousoulis D, Bartunek J, Vanderheyden M.

Curr Med Res Opin. 2020 Jan 6:1-7. doi: 10.1080/03007995.2019.1708286. [Epub ahead of print]

PMID:
31868029
3.

Acquired von Willebrand syndrome in patients on long-term left ventricular assist device support: Results of a Belgian center.

Deconinck SJ, Tersteeg C, Bailleul E, Delrue L, Vandeputte N, Pareyn I, Deckmyn H, De Meyer SF, Vanhoorelbeke K, Vanderheyden M.

Thromb Res. 2019 Dec;184:77-80. doi: 10.1016/j.thromres.2019.10.012. Epub 2019 Oct 21. No abstract available.

PMID:
31710861
4.

Biomarkers to predict the response to cardiac resynchronization therapy.

Heggermont W, Auricchio A, Vanderheyden M.

Europace. 2019 Nov 1;21(11):1609-1620. doi: 10.1093/europace/euz168.

PMID:
31681965
5.

Treatment of Diuretic Resistance with a Novel Percutaneous Blood Flow Regulator: Concept and Initial Experience.

Dierckx R, Vanderheyden M, Heggermont W, Goethals M, Verstreken S, Bartunek J.

J Card Fail. 2019 Nov;25(11):932-934. doi: 10.1016/j.cardfail.2019.08.017. Epub 2019 Aug 30.

PMID:
31476373
6.

Fractional flow reserve in patients with reduced ejection fraction.

Di Gioia G, De Bruyne B, Pellicano M, Bartunek J, Colaiori I, Fiordelisi A, Canciello G, Xaplanteris P, Fournier S, Katbeh A, Franco D, Kodeboina M, Morisco C, Van Praet F, Casselman F, Degrieck I, Stockman B, Vanderheyden M, Barbato E.

Eur Heart J. 2019 Aug 16. pii: ehz571. doi: 10.1093/eurheartj/ehz571. [Epub ahead of print]

PMID:
31419282
7.

Results of primary biventricular support: an analysis of data from the EUROMACS registry.

Vierecke J, Gahl B, de By TMMH, Antretter H, Beyersdorf F, Caliskan K, Krachak V, Loforte A, Potapov E, Schoenrath F, Stockman B, Vanderheyden M, Meyns B, Gummert J, Mohacsi P.

Eur J Cardiothorac Surg. 2019 Dec 1;56(6):1037-1045. doi: 10.1093/ejcts/ezz173.

PMID:
31369075
8.

Cardiac Resynchronization Therapy Optimization: A Comprehensive Approach.

Katbeh A, Van Camp G, Barbato E, Galderisi M, Trimarco B, Bartunek J, Vanderheyden M, Penicka M.

Cardiology. 2019;142(2):116-128. doi: 10.1159/000499192. Epub 2019 May 22. Review.

PMID:
31117077
9.

PROcedure related microvascular ACTIVation in long lEsions treated with bioresorbable vascular scaffold versus everolimus-eluting stent implantation (PROACTIVE trial).

Pellicano M, Di Gioia G, Ciccarelli G, Xaplanteris P, Delrue L, Toth GG, Van Durme F, Heyse A, Wyffels E, Vanderheyden M, Bartunek J, De Bruyne B, Barbato E.

EuroIntervention. 2019 May 14. pii: EIJ-D-18-01138. doi: 10.4244/EIJ-D-18-01138. [Epub ahead of print]

10.

Natriuretic Peptide Processing in Patients with and Without Left Ventricular Dysfunction.

Verstreken S, Delrue L, Goethals M, Bartunek J, Vanderheyden M.

Int Heart J. 2019 Jan 25;60(1):115-120. doi: 10.1536/ihj.18-012. Epub 2018 Dec 5.

11.

Imaging of Myocardial Fibrosis and Its Functional Correlates in Aortic Stenosis: A Review and Clinical Potential.

Katbeh A, Ondrus T, Barbato E, Galderisi M, Trimarco B, Van Camp G, Vanderheyden M, Penicka M.

Cardiology. 2018;141(3):141-149. doi: 10.1159/000493164. Epub 2018 Dec 5. Review.

12.

Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device-induced acquired von Willebrand syndrome.

Deconinck S, Tersteeg C, Bailleul E, Delrue L, Vandeputte N, Pareyn I, Itzhar-Baikian N, Deckmyn H, De Meyer SF, Vanderheyden M, Vanhoorelbeke K.

Res Pract Thromb Haemost. 2018 Oct 8;2(4):762-766. doi: 10.1002/rth2.12150. eCollection 2018 Oct.

13.

Left ventricular remodelling patterns after MitraClip implantation in patients with severe mitral valve regurgitation: mechanistic insights and prognostic implications.

Brouwer HJ, Den Heijer MC, Paelinck BP, Debonnaire P, Vanderheyden M, Van De Heyning CM, De Bock D, Coussement P, Saad G, Ferdinande B, Pouleur AC, Claeys MJ.

Eur Heart J Cardiovasc Imaging. 2019 Mar 1;20(3):307-313. doi: 10.1093/ehjci/jey088.

PMID:
30007315
14.

Left ventricular scar and the acute hemodynamic effects of multivein and multipolar pacing in cardiac resynchronization.

Jackson T, Lenarczyk R, Sterlinski M, Sokal A, Francis D, Whinnett Z, Van Heuverswyn F, Vanderheyden M, Heynens J, Stegemann B, Cornelussen R, Rinaldi CA.

Int J Cardiol Heart Vasc. 2018 Apr 10;19:14-19. doi: 10.1016/j.ijcha.2018.03.006. eCollection 2018 Jun.

15.

Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery.

Fournier S, Toth GG, De Bruyne B, Johnson NP, Ciccarelli G, Xaplanteris P, Milkas A, Strisciuglio T, Bartunek J, Vanderheyden M, Wyffels E, Casselman F, Van Praet F, Stockman B, Degrieck I, Barbato E.

Circ Cardiovasc Interv. 2018 Jun;11(6):e006368. doi: 10.1161/CIRCINTERVENTIONS.117.006368.

PMID:
29848611
16.

Resolving Apparent Inconsistencies Between Area, Flow, and Gradient Measurements in Patients With Aortic Valve Stenosis and Preserved Left Ventricular Ejection Fraction.

Mo Y, Penicka M, Di Gioia G, Barbato E, Ondrus T, Vanderheyden M, De Bruyne B, Bartunek J, Van Camp G.

Am J Cardiol. 2018 Mar 15;121(6):751-757. doi: 10.1016/j.amjcard.2017.11.047. Epub 2017 Dec 25.

PMID:
29395002
17.

The Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A protocol update.

Banovic M, Iung B, Bartunek J, Penicka M, Vanderheyden M, Casselman F, van Camp G, Nikolic S, Putnik S.

Am Heart J. 2018 Jan;195:153-154. doi: 10.1016/j.ahj.2017.10.005. Epub 2017 Oct 14. No abstract available.

PMID:
29224644
18.

Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation 2 Substudy.

Ciccarelli G, Barbato E, Toth GG, Gahl B, Xaplanteris P, Fournier S, Milkas A, Bartunek J, Vanderheyden M, Pijls N, Tonino P, Fearon WF, Jüni P, De Bruyne B.

Circulation. 2018 Apr 3;137(14):1475-1485. doi: 10.1161/CIRCULATIONAHA.117.028782. Epub 2017 Nov 21. Erratum in: Circulation. 2018 May 29;137(22):e820.

19.

Pitfalls in coronary artery stenosis assessment in takotsubo syndrome: The role of microvascular dysfunction.

Heyse A, Milkas A, Van Durme F, Barbato E, Lazaros G, Vanderheyden M, Bartunek J.

Hellenic J Cardiol. 2018 Sep - Oct;59(5):290-292. doi: 10.1016/j.hjc.2017.10.003. Epub 2017 Nov 13. No abstract available.

20.

Aortic valve replacement improves survival in severe aortic stenosis with gradient-area mismatch.

Mo Y, Van Camp G, Di Gioia G, Barbato E, Ondrus T, Casselman F, Vanderheyden M, De Bruyne B, Bartunek J, Penicka M.

Eur J Cardiothorac Surg. 2018 Mar 1;53(3):569-575. doi: 10.1093/ejcts/ezx362.

PMID:
29040507
21.

The impact of drop-out in cardiac rehabilitation on outcome among coronary artery disease patients.

Pardaens S, Willems AM, Clays E, Baert A, Vanderheyden M, Verstreken S, Du Bois I, Vervloet D, De Sutter J.

Eur J Prev Cardiol. 2017 Sep;24(14):1490-1497. doi: 10.1177/2047487317724574. Epub 2017 Jul 31.

PMID:
28758419
22.

Minimally invasive mitral valve annuloplasty confers a long-term survival benefit compared with state-of-the-art treatment in heart failure with functional mitral regurgitation.

Penicka M, Kotrc M, Ondrus T, Mo Y, Casselman F, Vanderheyden M, Van Camp G, Van Praet F, Bartunek J.

Int J Cardiol. 2017 Oct 1;244:235-241. doi: 10.1016/j.ijcard.2017.06.029. Epub 2017 Jun 8.

PMID:
28624330
23.

Platelet reactivity in patients carrying the e-NOS G894T polymorphism after a loading dose of aspirin plus clopidogrel.

Strisciuglio T, Di Gioia G, Mangiacapra F, De Biase C, Delrue L, Pellicano M, Bartunek J, Vanderheyden M, Izzo R, Trimarco B, Wijns W, Barbato E.

Thromb Res. 2017 Mar;151:72-73. doi: 10.1016/j.thromres.2017.01.011. Epub 2017 Jan 27. No abstract available.

PMID:
28160671
24.

Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.

Bartunek J, Terzic A, Davison BA, Filippatos GS, Radovanovic S, Beleslin B, Merkely B, Musialek P, Wojakowski W, Andreka P, Horvath IG, Katz A, Dolatabadi D, El Nakadi B, Arandjelovic A, Edes I, Seferovic PM, Obradovic S, Vanderheyden M, Jagic N, Petrov I, Atar S, Halabi M, Gelev VL, Shochat MK, Kasprzak JD, Sanz-Ruiz R, Heyndrickx GR, Nyolczas N, Legrand V, Guédès A, Heyse A, Moccetti T, Fernandez-Aviles F, Jimenez-Quevedo P, Bayes-Genis A, Hernandez-Garcia JM, Ribichini F, Gruchala M, Waldman SA, Teerlink JR, Gersh BJ, Povsic TJ, Henry TD, Metra M, Hajjar RJ, Tendera M, Behfar A, Alexandre B, Seron A, Stough WG, Sherman W, Cotter G, Wijns W; CHART Program.

Eur Heart J. 2017 Mar 1;38(9):648-660. doi: 10.1093/eurheartj/ehw543.

25.

Should MRAs be at the front row in heart failure? A plea for the early use of mineralocorticoid receptor antagonists in medical therapy for heart failure based on clinical experience.

Heggermont WA, Goethals M, Dierckx R, Verstreken S, Bartunek J, Vanderheyden M.

Heart Fail Rev. 2016 Nov;21(6):699-701. Review.

PMID:
27620301
26.

Minimally invasive mitral valve repair for functional mitral regurgitation in severe heart failure: MitraClip versus minimally invasive surgical approach.

Ondrus T, Bartunek J, Vanderheyden M, Stockman B, Kotrc M, Van Praet F, Van Camp G, Lecomte P, Mo Y, Penicka M.

Interact Cardiovasc Thorac Surg. 2016 Nov;23(5):784-789. Epub 2016 Jun 29.

PMID:
27357467
27.

In Heart Failure Patients with Left Bundle Branch Block Single Lead MultiSpot Left Ventricular Pacing Does Not Improve Acute Hemodynamic Response To Conventional Biventricular Pacing. A Multicenter Prospective, Interventional, Non-Randomized Study.

Sterliński M, Sokal A, Lenarczyk R, Van Heuverswyn F, Rinaldi CA, Vanderheyden M, Khalameizer V, Francis D, Heynens J, Stegemann B, Cornelussen R.

PLoS One. 2016 Apr 28;11(4):e0154024. doi: 10.1371/journal.pone.0154024. eCollection 2016.

28.

Direct coronary drainage to the left ventricle via Thebesian veins: series report with histologic and cardiac CT analysis.

Adjedj J, Meert V, Vanderheyden M, Van Mieghem C.

EuroIntervention. 2016 Apr 20;11(13):1564. doi: 10.4244/EIJV11I13A302. No abstract available.

29.

Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial.

Banovic M, Iung B, Bartunek J, Asanin M, Beleslin B, Biocina B, Casselman F, da Costa M, Deja M, Gasparovic H, Kala P, Labrousse L, Loncar Z, Marinkovic J, Nedeljkovic I, Nedeljkovic M, Nemec P, Nikolic SD, Pencina M, Penicka M, Ristic A, Sharif F, Van Camp G, Vanderheyden M, Wojakowski W, Putnik S.

Am Heart J. 2016 Apr;174:147-53. doi: 10.1016/j.ahj.2016.02.001. Epub 2016 Feb 9.

PMID:
26995381
30.

Novel device-based interventional strategies for advanced heart failure.

Toth GG, Vanderheyden M, Bartunek J.

Postepy Kardiol Interwencyjnej. 2016;12(1):13-6. doi: 10.5114/pwki.2016.56944. Epub 2016 Feb 11. Review.

31.

Wasted septal work in left ventricular dyssynchrony: a novel principle to predict response to cardiac resynchronization therapy.

Vecera J, Penicka M, Eriksen M, Russell K, Bartunek J, Vanderheyden M, Smiseth OA.

Eur Heart J Cardiovasc Imaging. 2016 Jun;17(6):624-32. doi: 10.1093/ehjci/jew019. Epub 2016 Feb 25.

32.

Impact of Right Atrial Pressure on Fractional Flow Reserve Measurements: Comparison of Fractional Flow Reserve and Myocardial Fractional Flow Reserve in 1,600 Coronary Stenoses.

Toth GG, De Bruyne B, Rusinaru D, Di Gioia G, Bartunek J, Pellicano M, Vanderheyden M, Adjedj J, Wijns W, Pijls NH, Barbato E.

JACC Cardiovasc Interv. 2016 Mar 14;9(5):453-9. doi: 10.1016/j.jcin.2015.11.021. Epub 2016 Feb 17. Erratum in: JACC Cardiovasc Interv. 2016 Oct 24;9(20):2181.

33.

Significance of Intermediate Values of Fractional Flow Reserve in Patients With Coronary Artery Disease.

Adjedj J, De Bruyne B, Floré V, Di Gioia G, Ferrara A, Pellicano M, Toth GG, Bartunek J, Vanderheyden M, Heyndrickx GR, Wijns W, Barbato E.

Circulation. 2016 Feb 2;133(5):502-8. doi: 10.1161/CIRCULATIONAHA.115.018747. Epub 2016 Jan 5.

PMID:
26733607
34.

Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling.

Baerts L, Waumans Y, Brandt I, Jungraithmayr W, Van der Veken P, Vanderheyden M, De Meester I.

PLoS One. 2015 Nov 6;10(11):e0141408. doi: 10.1371/journal.pone.0141408. eCollection 2015.

35.

Integrate and boost: bioscaffolds nurture the cardiac regenerative paradigm.

Bartunek J, Vanderheyden M, Behfar A.

Stem Cell Res Ther. 2015 Sep 23;6:183. doi: 10.1186/s13287-015-0184-0.

36.

Endpoints in stem cell trials in ischemic heart failure.

Banovic M, Loncar Z, Behfar A, Vanderheyden M, Beleslin B, Zeiher A, Metra M, Terzic A, Bartunek J.

Stem Cell Res Ther. 2015 Aug 29;6:159. doi: 10.1186/s13287-015-0143-9. Review.

37.

Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure.

Gayat E, Caillard A, Laribi S, Mueller C, Sadoune M, Seronde MF, Maisel A, Bartunek J, Vanderheyden M, Desutter J, Dendale P, Thomas G, Tavares M, Cohen-Solal A, Samuel JL, Mebazaa A.

Int J Cardiol. 2015 Nov 15;199:241-7. doi: 10.1016/j.ijcard.2015.07.039. Epub 2015 Jul 12.

PMID:
26209827
38.

Electrical remodeling reflected by QRS and T vector changes following cardiac resynchronization therapy is related to survival in heart failure patients with left bundle branch block.

Floré V, Bartunek J, Goethals M, Verstreken S, Timmermans W, De Pauw F, Van Bockstal K, Vanderheyden M.

J Electrocardiol. 2015 Jul-Aug;48(4):578-85. doi: 10.1016/j.jelectrocard.2015.02.004. Epub 2015 Feb 20.

PMID:
25747167
39.

Epicardial catheter-based ventricular reconstruction (ECVR) in a patient with ischemic heart failure and an anteroapical aneurysm.

Van Praet K, Stockman B, Vanderheyden M, Bartunek J, Casselman F.

Acta Clin Belg. 2015 Apr;70(2):141-4. doi: 10.1179/2295333714Y.0000000100. Epub 2014 Nov 20.

PMID:
25409627
40.

Impact of alpha- and beta-adrenergic receptor blockers on fractional flow reserve and index of microvascular resistance.

Barbato E, Sarno G, Berza CT, Di Gioia G, Bartunek J, Vanderheyden M, Di Serafino L, Wijns W, Trimarco B, De Bruyne B.

J Cardiovasc Transl Res. 2014 Dec;7(9):803-9. doi: 10.1007/s12265-014-9599-8. Epub 2014 Nov 1.

PMID:
25367207
41.
42.

Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry.

Nickenig G, Estevez-Loureiro R, Franzen O, Tamburino C, Vanderheyden M, Lüscher TF, Moat N, Price S, Dall'Ara G, Winter R, Corti R, Grasso C, Snow TM, Jeger R, Blankenberg S, Settergren M, Tiroch K, Balzer J, Petronio AS, Büttner HJ, Ettori F, Sievert H, Fiorino MG, Claeys M, Ussia GP, Baumgartner H, Scandura S, Alamgir F, Keshavarzi F, Colombo A, Maisano F, Ebelt H, Aruta P, Lubos E, Plicht B, Schueler R, Pighi M, Di Mario C; Transcatheter Valve Treatment Sentinel Registry Investigators of the EURObservational Research Programme of the European Society of Cardiology.

J Am Coll Cardiol. 2014 Sep 2;64(9):875-84. doi: 10.1016/j.jacc.2014.06.1166.

43.

Activation of the ergoreceptors in cardiac patients with and without heart failure.

Pardaens S, Vanderheyden M, Calders P, Willems AM, Bartunek J, de Sutter J.

J Card Fail. 2014 Oct;20(10):747-754. doi: 10.1016/j.cardfail.2014.07.006. Epub 2014 Jul 28.

PMID:
25079301
44.

Percutaneous mitral valve repair in high-risk patients: initial experience with the Mitraclip system in Belgium.

Vandendriessche T, Kotrc M, Tijskens M, Bartunek J, Delesie M, Paelinck BP, De Bock D, Penicka M, Stockman B, De Maeyer C, Vrints C, Vanderheyden M, Claeys MJ.

Acta Cardiol. 2014 Jun;69(3):265-70.

PMID:
25029871
45.

Self-limiting left ventricular wall rupture following myocardial infarction: a case report and literature review.

Vervaeke H, Becaus N, Penicka M, Vanderheyden M.

Acta Cardiol. 2014 Apr;69(2):209-12. Review.

PMID:
24783477
46.

Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses.

Toth G, Hamilos M, Pyxaras S, Mangiacapra F, Nelis O, De Vroey F, Di Serafino L, Muller O, Van Mieghem C, Wyffels E, Heyndrickx GR, Bartunek J, Vanderheyden M, Barbato E, Wijns W, De Bruyne B.

Eur Heart J. 2014 Oct 21;35(40):2831-8. doi: 10.1093/eurheartj/ehu094. Epub 2014 Mar 18.

PMID:
24644308
47.

Impact of the preoperative risk and the type of surgery on exercise capacity and training after valvular surgery.

Pardaens S, Moerman V, Willems AM, Calders P, Bartunek J, Vanderheyden M, De Sutter J.

Am J Cardiol. 2014 Apr 15;113(8):1383-9. doi: 10.1016/j.amjcard.2014.01.413. Epub 2014 Jan 31.

PMID:
24576546
48.

Integration of remote monitoring of device diagnostic parameters into a multidisciplinary heart failure management program.

Dierckx R, Houben R, Goethals M, Verstreken S, Bartunek J, Saeys R, De Proft M, Boel E, Vanderheyden M.

Int J Cardiol. 2014 Apr 1;172(3):606-7. doi: 10.1016/j.ijcard.2014.01.088. Epub 2014 Jan 24. No abstract available.

PMID:
24507743
49.

Reply: The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE).

Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, El Nakadi B, Banovic M, Beleslin B, Vrolix M, Legrand V, Vrints C, Vanoverschelde JL, Crespo-Diaz R, Homsy C, Tendera M, Waldman S, Wijns W, Terzic A.

J Am Coll Cardiol. 2013 Dec 24;62(25):2454-2456. doi: 10.1016/j.jacc.2013.09.014. No abstract available.

50.

Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.

Puymirat E, Mangiacapra F, Peace A, Ntarladimas Y, Conte M, Bartunek J, Vanderheyden M, Wijns W, de Bruyne B, Barbato E.

Arch Cardiovasc Dis. 2013 Nov;106(11):554-61. doi: 10.1016/j.acvd.2013.06.056. Epub 2013 Nov 11.

Supplemental Content

Loading ...
Support Center